When to Perform HIDA Scan with CCK
Perform a CCK-HIDA scan in well-selected patients who present with upper abdominal pain consistent with biliary colic but have a normal-appearing gallbladder on ultrasound (no gallstones). 1
Primary Indication
The primary indication for CCK-HIDA scanning is suspected functional gallbladder disorder (also called biliary dyskinesia, chronic acalculous cholecystitis, or gallbladder dyskinesia). 1
Clinical Presentation Required:
- Biliary-type pain: Upper abdominal pain thought to be biliary in origin 1
- Normal ultrasound: No evidence of cholelithiasis or structural gallbladder abnormalities 1
- Outpatient setting: The test should be performed when the patient is stable and not acutely ill or hospitalized, as acute illness and medications can spuriously decrease gallbladder ejection fraction 1
Patient Selection Criteria
The test should only be ordered after appropriate initial workup:
- Normal transabdominal ultrasound demonstrating no gallstones 2
- Normal upper GI endoscopy to exclude other causes 2
- Symptoms consistent with typical biliary colic (right upper quadrant or epigastric pain, often postprandial) 1
Important caveat: In patients with typical biliary symptoms and negative ultrasound, approximately 4% will have an abnormal HIDA scan, making careful patient selection critical. 2
Standardized Protocol Recommendations
When performing CCK-HIDA, the consensus guideline recommends: 1
- Dose: 0.02 μg/kg of sincalide (CCK)
- Infusion duration: 60 minutes (not the rapid 15-30 minute protocols)
- Normal ejection fraction: ≥38%
- Abnormal ejection fraction: <38%
The 60-minute infusion protocol has significantly less variability (19% coefficient of variation) compared to shorter infusions (52% for 15-minute, 35% for 30-minute protocols). 1
Patient Preparation Requirements
Critical preparation steps to avoid false positives: 1
- Fasting: Minimum 4-6 hours, optimally overnight
- Medication withholding:
- Opiates and anticholinergics: 48 hours prior
- Nifedipine, indomethacin, octreotide, theophylline, benzodiazepines: 24 hours prior
- Nicotine and alcohol: avoid prior to testing
- Contraindications: Known allergy to sincalide, intestinal obstruction, pregnancy 1
Clinical Utility and Outcomes
The evidence for CCK-HIDA effectiveness varies by clinical presentation:
- Typical biliary symptoms with EF <50%: 94.5% improvement or cure rate after cholecystectomy 3
- Typical biliary symptoms with positive HIDA: 66% symptom resolution 4
- Atypical symptoms with positive HIDA: 64% symptom resolution (significantly better than negative HIDA at 43%) 4
- Symptom reproduction with CCK: Superior predictor to ejection fraction alone, with 97.6% remaining symptom-free at mean 18.7 months follow-up 5
Important clinical pearl: A 2015 study found that HIDA scan with ejection fraction was not useful in patients with typical symptoms of biliary colic and negative ultrasounds for making cholecystectomy decisions, but was helpful in patients with atypical symptoms. 4 This represents an important nuance in the literature, though the consensus guideline still supports its use in well-selected patients with typical symptoms. 1
Common Pitfalls to Avoid
- Ordering in hospitalized/acutely ill patients: Acute illness falsely lowers ejection fraction 1
- Inadequate patient preparation: Failure to withhold interfering medications or ensure proper fasting 1
- Using rapid infusion protocols: The 15-30 minute protocols have excessive variability and lower normal cutoffs (13-17%) 1
- Ignoring symptom reproduction: Reproduction of typical pain with CCK infusion may be more predictive than ejection fraction alone 5
- Overutilization: The test should not be used as a screening tool but reserved for carefully selected patients after excluding other causes 4
Special Consideration: Hyperkinetic Gallbladder
Emerging evidence suggests that high ejection fraction (≥80%) may also warrant cholecystectomy, with 95.9% symptom resolution reported in one series, though this remains less established than low ejection fraction. 6